Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M27,754Revenue $M1,212Net Margin (%)-65.8Z-Score10.4
Enterprise Value $M27,086EPS $-2.0Operating Margin %-107.1F-Score4
P/E(ttm))0Cash Flow Per Share $-0.3Pre-tax Margin (%)-117.7Higher ROA y-yY
Price/Book24.010-y EBITDA Growth Rate %0Quick Ratio4.4Cash flow > EarningsY
Price/Sales34.15-y EBITDA Growth Rate %0Current Ratio4.4Lower Leverage y-yN
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-22.3Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-41.9Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M238ROI % (ttm)-31.5Gross Margin Increase y-yY

Gurus Latest Trades with VRTX

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
VRTXKen Fisher 2014-09-30 Reduce$84.74 - $113.9
($94.97)
$ 115.3922%Reduce -31.99%4,593
VRTXKen Fisher 2014-06-30 Buy $62.44 - $93.77
($69.73)
$ 115.3966%New holding, 6753 sh.6,753
VRTXJohn Burbank 2014-06-30 Sold Out -0.01%$62.44 - $93.77
($69.73)
$ 115.3966%Sold Out0
VRTXGeorge Soros 2014-06-30 Sold Out -0.01%$62.44 - $93.77
($69.73)
$ 115.3966%Sold Out0
VRTXVanguard Health Care Fund 2014-03-31 Add0.13%$67.8 - $85.48
($79.08)
$ 115.3946%Add 5.89%11,628,500
VRTXGeorge Soros 2014-03-31 Buy 0.01%$67.8 - $85.48
($79.17)
$ 115.3946%New holding, 10000 sh.10,000
VRTXJohn Burbank 2014-03-31 Buy 0.01%$67.8 - $85.48
($79.17)
$ 115.3946%New holding, 2872 sh.2,872
VRTXVanguard Health Care Fund 2013-12-31 Add0.88%$60.18 - $77.83
($69.45)
$ 115.3966%Add 54.06%10,981,500
VRTXVanguard Health Care Fund 2013-09-30 Add0.29%$74.53 - $88.51
($79.62)
$ 115.3945%Add 19%7,127,997
VRTXVanguard Health Care Fund 2013-06-30 Add1.05%$52.6 - $85.6
($73.64)
$ 115.3957%Add 140.58%5,990,000
VRTXAndreas Halvorsen 2013-06-30 Sold Out -0.26%$52.6 - $85.6
($73.64)
$ 115.3957%Sold Out0
VRTXNWQ Managers 2013-06-30 Sold Out -0.09%$52.6 - $85.6
($73.64)
$ 115.3957%Sold Out0
VRTXAndreas Halvorsen 2013-03-31 Buy 0.26%$41.9 - $54.97
($47.91)
$ 115.39141%New holding, 780500 sh.780,500
VRTXNWQ Managers 2013-03-31 Reduce-0.02%$41.9 - $54.97
($47.91)
$ 115.39141%Reduce -23.44%191,032
VRTXDaniel Loeb 2012-12-31 Sold Out -0.77%$38.88 - $59.42
($46.08)
$ 115.39150%Sold Out0
VRTXJohn Burbank 2012-12-31 Sold Out -0.38%$38.88 - $59.42
($46.08)
$ 115.39150%Sold Out0
VRTXDaniel Loeb 2012-09-30 Add0.22%$48.38 - $59.07
($53.5)
$ 115.39116%Add 40%700,000
VRTXJohn Burbank 2012-09-30 Reduce-0.09%$48.38 - $59.07
($53.5)
$ 115.39116%Reduce -25%150,000
VRTXGeorge Soros 2012-09-30 Sold Out -0.09%$48.38 - $59.07
($53.5)
$ 115.39116%Sold Out0
VRTXJoel Greenblatt 2012-09-30 Sold Out -0.08%$48.38 - $59.07
($53.5)
$ 115.39116%Sold Out0
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

VRTX is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
VRTX Vanguard Health Care Fund 2014-09-3011,807,5004.963.4
VRTX Ken Fisher 2014-09-304,59300-31.99%
Premium Most recent portfolio changes are included for Premium Members only!


VRTX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
BOGER JOSHUA SDirector 2014-11-19Sell10,500$114.750.56view
Connolly ThomasSVP, Human Resources 2014-11-17Sell153$111.873.15view
Pace Megan ESVP, Corp. Communications 2014-11-17Sell33$111.933.09view
Sachdev AmitEVP, Policy, Access & Value 2014-11-17Sell134$111.973.05view
BOGER JOSHUA SDirector 2014-11-12Sell10,500$116.13-0.64view
SACHS BRUCE IDirector 2014-11-06Sell9,900$115.210.16view
Silva Paul MSVP & Corp Controller 2014-11-05Sell1,687$112.562.51view
Connolly ThomasSVP, Human Resources 2014-11-05Sell937$112.542.53view
BOGER JOSHUA SDirector 2014-11-05Sell10,500$112.262.79view
Arbuckle Stuart AEVP\Chief Commercial Officer 2014-11-05Sell4,250$112.52.57view

Press Releases about VRTX :

    Quarterly/Annual Reports about VRTX:

    News about VRTX:

    Articles On GuruFocus.com
    Weekly CFO Sells Highlight: Texas Instruments Inc, Royal Caribbean Cruises Ltd, Vertex Pharmaceutica Nov 09 2014 
    Weekly CFO Sells Highllight: Facebook Inc, Vertex Pharmaceuticals Inc, Nike Inc. Oct 05 2014 
    Vanguard Health Care Fund Buys Vertex Pharmaceuticals, Zoetis Inc, , Sells Cerner Corporation, AbbVi Aug 02 2013 
    Weekly Guru Bargains Highlights: MBI, VRTX, GRPN, PBI, PC Dec 16 2012 
    WEEKLY CFO SELLS HIGHLIGHT: AKRX, FIO, OVRL, VRTX Oct 21 2012 
    Idenix Pharmaceuticals Lagging Behind in Breakthrough Hepatitis C Drug Development Jul 13 2012 
    Weekly Top Insider Sells: GMCR, VRTX, CERN, and AGN May 14 2012 
    Vertex Could Climb On New Drug, VX-222 Success Apr 21 2012 
    Achillion Will Surge If New Drug Is Successful Apr 21 2012 
    Columbia Management Fourth Quarter Letter with Comments on SWK, AGCO, CE, MCP, VRTX, DOLE, F, HAS, A Apr 10 2012 

    More From Other Websites
    Biotech Stock Roundup: BioMarin to Acquire Prosensa, AbbVie HCV Therapy Closer to EU Approval Nov 26 2014
    Today's Stocks Driving Success For The Drugs Industry Nov 25 2014
    It was another slow, low volume, lackluster trading session Nov 24 2014
    Vertex to Present at Deutsche Bank BioFEST on December 2 Nov 20 2014
    Vertex to Present at Deutsche Bank BioFEST on December 2 Nov 20 2014
    Insider Trading Alert - LNKD, VRTX And RLGY Traded By Insiders Nov 20 2014
    The S&P failed to extend its 4-day winning streak following headlines out of the Fed Nov 19 2014
    Foundation sells $3.3B in Vertex drug royalties Nov 19 2014
    Foundation sells $3.3B in Vertex drug royalties Nov 19 2014
    Royalty Pharma's $3.3 Billion Transaction is Bullish for Vertex Pharma Nov 19 2014
    Midday movers: Target, JetBlue, Qualcomm & more Nov 19 2014
    Barbarian At The Gate: Vertex Pharmaceuticals (VRTX) Nov 19 2014
    3 Drugs Stocks Driving The Industry Higher Nov 19 2014
    Royalty Pharma buys royalties on Vertex Pharma drugs for $3.3 bln Nov 19 2014
    Royalty Pharma Pays $3.3 Billion for Cystic Fibrosis Royalties Nov 19 2014
    VERTEX PHARMACEUTICALS INC / MA Financials Nov 14 2014
    Biotech Stock Roundup: Gilead, AbbVie Score at Liver Meeting, Dendreon Files for Bankruptcy Nov 12 2014
    Vertex Pharmaceuticals Seeks Approval for CF Combination Nov 06 2014
    VERTEX PHARMACEUTICALS INC / MA Files SEC form 10-Q, Quarterly Report Nov 06 2014
    3 Stocks Moving The Drugs Industry Upward Nov 06 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK